Stock Earnings

Question 1

What are Opus Genetics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Opus Genetics Inc has a total asset of $36, Net loss of $-57

Question 2

What are the key financial ratios for IRD?

Accepted Answer

Opus Genetics Inc's Current ratio is 3.27, has a Net margin is -570, sales per share of $0.37.

Question 3

How is Opus Genetics Inc's revenue broken down by segment or geography?

Accepted Answer

Opus Genetics Inc largest revenue segment is Vision Performance and Health, at a revenue of 10,992,000 in the most earnings release.For geography, United States is the primary market for Opus Genetics Inc, at a revenue of 10,992,000.

Question 4

Is Opus Genetics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Opus Genetics Inc has a net loss of $-57

Question 5

Does Opus Genetics Inc have any liabilities?

Accepted Answer

yes, Opus Genetics Inc has liability of 11

Question 6

How many outstanding shares for Opus Genetics Inc?

Accepted Answer

Opus Genetics Inc has a total outstanding shares of 31.57

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	15	10	19	39	0	0
Revenue Growth (YoY)	-6%	-47%	-51%	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	19	15	9	7	8	2
Research & Development	29	26	17	14	15	6
Operating Expenses	49	42	27	21	23	9
Other Non Operating Income (Expenses)	5	4	1	0	0	0
Pretax Income	-58	-57	-9	18	-56	-24
Income Tax Expense	0	0	0	0	0	0
Net Income	-58	-57	-9	17	-56	-24
Net Income Growth	314%	533%	-153%	-130%	133%	200%
Shares Outstanding (Diluted)	63.37	26.71	21.58	20.6	14.85	4.66
Shares Change (YoY)	145%	24%	5%	39%	219%	371%
EPS (Diluted)	-0.91	-2.15	-0.46	0.87	-3.82	-5.28
EPS Growth	66%	366%	-153%	-123%	-28%	-39%
Free Cash Flow	-31	-25	-1	14	-19	-6
Free Cash Flow Per Share	-0.48	-0.93	-0.04	0.67	-1.27	-1.28
Gross Margin	--	--	--	--	--	--
Operating Margin	-226.66%	-310%	-42.1%	46.15%	0%	0%
Profit Margin	-386.66%	-570%	-47.36%	43.58%	0%	0%
Free Cash Flow Margin	-206.66%	-250%	-5.26%	35.89%	0%	0%
EBITDA	-34	-31	-8	18	-22	-9
EBITDA Margin	-226.66%	-310%	-42.1%	46.15%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-34	-31	-8	18	-22	-9
EBIT Margin	-226.66%	-310%	-42.1%	46.15%	0%	0%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Opus Genetics Inc (IRD) Price

IRD Stock Price Chart

IRD Income

Follow-Up Questions